ITOS
Iteos Therapeutics, Inc.
CEO Michel Detheux sold $2.0M of Iteos Therapeutics, Inc.
Sold$1,982,131
$44.54Price
44,500Shares
−41%Stake
What ITOS did after the filing
- The stock from Wed, Dec 22 close, $46.01
- −21.5%
- S&P 500, same days
- −4.1%
Measured over 30 trading days, to the Feb 4 close.
Traded Mon, Dec 20. Filed Wed, Dec 22, 3:01 PM ET, during the session. Returns use the Dec 22 close and the Feb 4 close. Not investment advice.